Zenex to Acquire Ayurvet to Enhance its Animal Health Business
Shots:
- Zenex has signed an agreement to acquire Ayurvet, a subsidiary of Dabur India for an undisclosed amount to strengthen its animal health portfolio & to meet customer requirements locally & across the globe
- With the acquisition, Zenex gets hold of Ayurvet’s broad spectrum of animal health products, research capabilities, sales and management team along with an access to Ayurvet’s global presence
- Earlier, In Jul 2021, Zenex and Zydus signed a Business Transfer Agreement wherein Zenex would purchase Zydus' animal healthcare business. Zydus proposed a wish to sell its animal health business to companies in India and other countries for an aggregate of ~$369.98M
Ref: Zenex | Image: Zenex
Related News:- Jaguar Animal Health Reports an Availability of Canalevia-CA1 on Chewy for Chemotherapy-Induced Diarrhea in Dogs
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Kritika is a content writer at PharmaShots. She is interested in covering recent innovations from the pharma & MedTech industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
